The results “underscore the transformative potential of targeting obesity” to protect against a broad spectrum of health threats, Harlan Krumholz, a professor at the Yale School of Medicine, said in a statement.

European drug regulators have concluded that popular medications for diabetes and weight loss, such as Ozempic and Wegovy, do not…

An experimental weight-loss injection developed by Amgen Inc., administered less frequently compared to popular treatments from Eli Lilly & Co.…